Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis

Cancer

Volumn 77, Issue 9, 1996, Pages 1823-1830

  Le Doussal, Viviane ^a,g,h   Coindre, Jean Michel ^b,g   Leroux, Agnès ^c,g   Hacene, Kamel ^a,g   Terrier, Philippe ^d,g   Bui, N'guyen Binh ^b,g   Bonichon, Françoise ^b,g   Collin, Françoise ^e,g   Mandard, Anne Marie ^f,g   Contesso, Geneviève ^d,g  

^a Anticancer Center   (France)

^b Anticancer Center   (France)

^c Anticancer Center   (France)

^d Department of Pathology   (France)

^e Anti Cancer Center   (France)

^f Department of Pathology   (France)

^g Fr Fed Cancer Centers Sarcoma Grp   (France)

^h CENTRE RENÉ HUGUENIN   (France)

Author keywords

malignant fibrous histiocytoma; multivariate analysis; prognosis; soft tissue sarcoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SOFT TISSUE SARCOMA; TUMOR VOLUME;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; INFORMATION SYSTEMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0006611518     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1823::AID-CNCR10>3.0.CO;2-1     Document Type: Article

References (36)

1. Kauffman SL, Stout AP. Histiocytic tumors (fibrous xanthoma and histiocytoma) in children. Cancer 1961;14:469-82.
2. O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer 1964;17:1445-58.
3. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978;41:2250-66.
4. Ekfors TO, Rantakokko V. An analysis of 38 malignant fibrous histiocytomas in the extremities. Acta Pathol Microbiol Immunol Scand 1978;86:25-35.
5. Enjoji M, Hashimoto H, Tsuneyoshi M, Iwasaki H. Malignant fibrous histiocytoma: a clinicopathologic study of 130 cases. Acta Pathol Jpn 1980;30(5):721-45.
6. Kearney MM, Soule EH, Ivins JC. Malignant fibrous histiocytoma: a retrospective study of 167 cases. Cancer 1980;45: 167-78.
7. Tewfik HH, Tewfik FA, Latourette HB. Malignant fibrous histiocytoma: a retrospective evaluation of 24 patients. J Surg Oncol 1981;16:189-97.
8. Bertoni F, Capanna R, Biagini R, Bacchini P, Guerra A, Ruggieri P, et al. Malignant fibrous histiocytoma of soft-tissue: analysis of 78 cases located and deeply seated in the extremities. Cancer 1985;56:356-67.
9. Rööser BO, Willen H, Gustaffson P, Alvegärd TA, Rydholm A. Malignant fibrous histiocytoma of soft-tissue. A population-based epidemiologic and prognostic study of 137 patients. Cancer 1991;67:499-505.
10. Pezzi ME, Rawling MS, Esgro JJ, Pollock RE, Romsdahl MM. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992;69:2098-103.
11. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16, 3:213-28.
12. Weiss SW. Malignant fibrous histiocytoma. A reaffirmation. Am J Surg Pathol 1982;6(8):773-84.
13. Weiss SW. Histological typing of soft-tissue tumours World Health Organization. 2nd edition. Geneva: Springer-Verlag, 1994.
14. Markhede G, Angervall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 1982;49:1721-33.
15. Heise HN, Myers MH, Russell WO, Suit HD, Enzinger FM, Edmonson J, et al. Recurrence-free survival time for surgically treated soft-tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 1986;57:172-7.
16. Alvegard TA, Berg NO, Baldetorp B, Fernö M, Killander D, Ranstam J, et al. Cellular DNA content and prognosis of high grade soft-tissue sarcoma. The Scandinavian sarcoma group experience. J Clin Oncol 1990;8:538-47.
17. Saddegh MK, Lindholm J, Lundberg A, Nilsonne U, Kreicbergs A. Staging of soft-tissue sarcoma. Prognostic analysis of clinical and pathological features. J Bone Joint Surg Am 1992;74:495-500.
18. Ravaud A, Bui NB, Coindre JM, Lagarde P, Tramond P, Bonichon F, et al. Prognostic variables for the selection of patients with operable soft-tissue sarcomas to be considered in adjuvant chemotherapy trials. Br J Cancer 1992;66:961-9.
19. Bears OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging cancer. American Joint Committee on Cancer. Staging UICC. 4th edition. Philadelphia: J.B. Lippincott, 1992.
20. Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M. Prognostic significance of histologic parameters of soft-tissue sarcomas. Cancer 1992;70:2816-22.
21. Yang JG, Rosenberg SA, Glatstein EJ, Antman KH. Sarcomas of soft-tissues. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 4th edition. Philadelphia: J.B. Lippincott, 1993:1436-85.
22. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, et al. Refinement of clinicopathologic staging for localized soft-tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 1992;10:1317-29.
23. Enzinger FM, Weiss SW. Malignant fibrohistiocytic tumors. In: Soft-tissue tumors. 2nd edition. St Louis: CV Mosby Company, 1988:269-300.
24. Trojani M, Contesso G, Coindre JM, Rouëssé J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults, study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42.
25. Coindre JM, Trojani M, Contesso G, David M, Rouëssé J, Bui NB, et al. Reproducibility of a histopathologic grading system for adult soft-tissue sarcoma. Cancer 1986;58:306-9.
26. Miller R, Siegmund D. Maximally selected Chi-square statistics. Biometrics 1982;38(4):1011-6.
27. Kaplan EK, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
28. Peto R, Pike MC, Armitage P, Breslow DR, Howard SV, Mantel N, et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patients. Part II. Analyses and examples. Br J Cancer 1977;35:1-39.
29. Cox DR. Regression models and life tables. JR Stat Soc (B) 1972;34:187-220.
30. SAS Institute. SUGI supplemental library user's guide. Cary, NC: SAS Institute, 1986.
31. Weiss SW, Enzinger FM. Myxoid variant of malignant fibrous histiocytoma. Cancer 1977;39:1672-85.
32. Bell RS, O'Sullivan B, Liu FF, Powell J, Langer F, Fornasier VL, et al. The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am 1989;71:370-5.
33. Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, de Ranierie E, et al. Prognostic factors in soft-tissue sarcomas. A multivariate analysis of 109 cases. Cancer 1989;63:1437-51.
34. Becker RL, Venzon D, Lack EE, Mikel UV, Weiss SW, O'Leary TJ. Cytometry and morphometry of malignant fibrous histiocytoma of the extremities. Prediction of metastasis and mortality. Am J Surg Pathol 1991;15(10):957-64.
35. Zehr RJ, Bauer TW, Marks KE, Weltevreden A. Ki-67 and grading of malignant fibrous histiocytoma. Cancer 1990; 66:1984-90.
36. Rydholm A, Mandahl N, Heim S, Kreicberg A, Willein H, Mitelman F. Malignant fibrous histiocytoma with a 19 p + marker chromosome have increased relapse rate. Genes Chromosom Cancer 1990;2(4):296-9.